Epleptin 100, 300, 400 mg Capsule
PDF Leaflet Revision Date: 09 September 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Adjunctive therapy for seizure control in epilepsy.
Dosage (summary)
900-1800 mg/day in three divided doses for adults and children over 12.
Special Populations
- Elderly
- Renal impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation.
Key Drug Interactions
- CNS depressants
- Opioids
- Antacids
Contraindications
- Hypersensitivity to gabapentin
- Severe renal impairment
- Children under 12
Common side effects
- Somnolence
- Dizziness
- Ataxia
- Nausea
Counselling Points
- Monitor for signs of suicidal thoughts
- Avoid abrupt discontinuation
- Use caution when driving or operating machinery
Serious warnings
- Risk of suicidal ideation
- Abrupt withdrawal may precipitate seizures
- Severe hypersensitivity reactions
Important Disclaimer
The Epleptin 100, 300, 400 mg Capsule professional information leaflet below is the property of Ranbaxy Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
